{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T18:44:17Z","timestamp":1792349057825,"version":"4.4.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Alma Mater Studiorum - Universit\u00e0 di Bologna"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>A rare subset of somatic tumors shows a striking resemblance to yolk sac tumors (YSTs) of germ cell origin, including somatic carcinomas with YST\/enteroblastic differentiation, fetal lung adenocarcinomas (FLACs), and YSTs in older (\u2265\u200940 years) females. These somatic tumors express markers such as SALL4, glypican 3 (GPC 3) and alpha-fetoprotein (\u03b1FP). However, it is currently unclear to what extent they express FOXA2, HNF1\u03b2, and SOX17, which are pioneer transcription factors and key drivers of YST differentiation and stain the vast majority of chemotherapy-na\u00efve YSTs of germ cell origin. Therefore, a multi-institutional series of seven somatically derived \u201cYST-like\u201d tumors was assembled and evaluated with a comprehensive panel of YST related markers (SALL4, FOXA2, HNF1\u03b2, SOX17, \u03b1FP, GATA3, and CDX2), to evaluate the potential involvement of FOXA2, HNF1\u03b2, and SOX17 in the biology of these tumors. FOXA2 and HNF1\u03b2 were positive in all (7\/7, 100%) YST-like tumors, followed by CDX2 (6\/7, 85.7%) and SALL4 (5\/7, 71.4%). In contrast, SOX17, GATA3, \u03b1FP, and GPC3 were positive in fewer cases, and showed lower percentages and intensities. Four of seven (57.1%) YST-like tumors showed synchronous\/accompanying somatic neoplastic components: one clear cell carcinoma of the ovary, two urothelial carcinomas of the bladder, and one invasive non-mucinous (conventional) adenocarcinoma of the lung. HNF1\u03b2 stained all these components (4\/4, 100%), and all of them (4\/4, 100%) stained for at least two of the YST markers evaluated (range: 2\u20134). In conclusion, our results support the use of an immunohistochemical panel to diagnose YST-like tumors, considering not only the most frequently expressed makers (FOXA2 and HNF1\u03b2), but also the potential expression (particularly of HNF1\u03b2) by the associated somatic neoplastic components lacking an overt YST phenotype. The consistent expression of FOXA2 and HNF1\u03b2 (but not SOX17) in our cohort underscores the phenotypic overlap between YST-like tumors and YSTs of germ cell origin (type II), including shared expression of multiple pioneer transcription factors which drive the YST phenotype.<\/jats:p>","DOI":"10.1007\/s00428-026-04622-y","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T03:55:36Z","timestamp":1781754936000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Immunohistochemical characterization of somatically derived \u201cyolk sac tumors\u201d: analysis of a multi-institutional case series"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7254-4195","authenticated-orcid":false,"given":"Costantino","family":"Ricci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"De Leo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Grillini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnese","family":"Orsatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Fernanda-Pontes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuno Tiago","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ambrosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Grillini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Franchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Vasuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Nosseir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Mollica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Massari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres Martin","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelangelo","family":"Fiorentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huili","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezra","family":"Baraban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"issue":"12","key":"4622_CR1","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1002\/ijc.21747","volume":"118","author":"F Bray","year":"2006","unstructured":"Bray F, Richiardi L, Ekbom A et al (2006) Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality. Int J Cancer 118(12):3099\u2013111","journal-title":"Int J Cancer"},{"issue":"5","key":"4622_CR2","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/his.15249","volume":"85","author":"A Fichtner","year":"2024","unstructured":"Fichtner A, Nettersheim D, Bremmer F (2024) Pathogenesis and pathobiology of testicular germ cell tumours: a view from a developmental biological perspective with guidelines for pathological diagnostics. Histopathology 85(5):701\u201315","journal-title":"Histopathology"},{"issue":"4","key":"4622_CR3","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/his.14675","volume":"81","author":"DM Berney","year":"2022","unstructured":"Berney DM, Cree I, Rao V et al (2022) An introduction to the WHO 5th edition 2022 classification of testicular tumours. Histopathology 81(4):459\u201366","journal-title":"Histopathology"},{"issue":"9","key":"4622_CR4","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/s41568-019-0178-9","volume":"19","author":"JW Oosterhuis","year":"2019","unstructured":"Oosterhuis JW, Looijenga LHJ (2019) Human germ cell tumours from a developmental perspective. Nat Rev Cancer 19(9):522\u201337","journal-title":"Nat Rev Cancer"},{"key":"4622_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154540","volume":"247","author":"S Melotti","year":"2023","unstructured":"Melotti S, Ambrosi F, Franceschini T et al (2023) TAMs PD-L1(+) in the reprogramming of germ cell tumors of the testis. Pathol Res Pract 247:154540","journal-title":"Pathol Res Pract"},{"issue":"8","key":"4622_CR6","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1111\/jcmm.13082","volume":"21","author":"D Nettersheim","year":"2017","unstructured":"Nettersheim D, Schorle H (2017) The plasticity of germ cell cancers and its dependence on the cellular microenvironment. J Cell Mol Med 21(8):1463\u20137","journal-title":"J Cell Mol Med"},{"issue":"2","key":"4622_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20020258","volume":"20","author":"J Lobo","year":"2019","unstructured":"Lobo J, Gillis AJM, Jer\u00f3nimo C et al (2019) Human germ cell tumors are developmental cancers: impact of epigenetics on pathobiology and clinic. Int J Mol Sci 20(2):258","journal-title":"Int J Mol Sci"},{"issue":"9","key":"4622_CR8","doi-asserted-by":"publisher","first-page":"100807","DOI":"10.1016\/j.modpat.2025.100807","volume":"38","author":"J Lobo","year":"2025","unstructured":"Lobo J, Tavares NT, Fernandes-Pontes F et al (2025) Phenotypic and Molecular Features of Somatically Derived Yolk Sac Tumors: Similarities and Differences With Counterparts of Germ Cell Origin. Mod Pathol 38(9):100807","journal-title":"Mod Pathol"},{"issue":"11","key":"4622_CR9","doi-asserted-by":"publisher","first-page":"100829","DOI":"10.1016\/j.modpat.2025.100829","volume":"38","author":"L Beauchamp","year":"2025","unstructured":"Beauchamp L, Elias R, Toll AD et al (2025) Extragonadal Urinary Tract Neoplasms With Yolk Sac Differentiation: Clinical, Histologic, and Molecular Evidence of Derivation From Underlying Urothelial Carcinoma. Mod Pathol 38(11):100829","journal-title":"Mod Pathol"},{"issue":"5","key":"4622_CR10","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/his.14188","volume":"77","author":"AM Acosta","year":"2020","unstructured":"Acosta AM, Sholl LM, Cin PD et al (2020) Malignant tumours of the uterus and ovaries with Mullerian and germ cell or trophoblastic components have a somatic origin and are characterised by genomic instability. Histopathology 77(5):788\u201397","journal-title":"Histopathology"},{"issue":"7","key":"4622_CR11","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1097\/PAS.0000000000002389","volume":"49","author":"TA Numan","year":"2025","unstructured":"Numan TA, Ronnett BM, Haley L et al (2025) Clinicopathologic and molecular analysis of malignant neoplasms with yolk sac tumor differentiation in women 40 years of age and older. Am J Surg Pathol 49(7):686\u2013700","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"4622_CR12","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1038\/s41379-020-0548-6","volume":"33","author":"SL Skala","year":"2020","unstructured":"Skala SL, Liu CJ, Udager AM et al (2020) Molecular characterization of uterine and ovarian tumors with mixed epithelial and germ cell features confirms frequent somatic derivation. Mod Pathol 33(10):1989\u20132000","journal-title":"Mod Pathol"},{"issue":"5","key":"4622_CR13","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1097\/PGP.0b013e3182164386","volume":"30","author":"LM Roth","year":"2011","unstructured":"Roth LM, Talerman A, Levy T et al (2011) Ovarian yolk sac tumors in older women arising from epithelial ovarian tumors or with no detectable epithelial component. Int J Gynecol Pathol 30(5):442\u201351","journal-title":"Int J Gynecol Pathol"},{"issue":"5","key":"4622_CR14","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/his.13021","volume":"69","author":"T McNamee","year":"2016","unstructured":"McNamee T, Damato S, McCluggage WG (2016) Yolk sac tumours of the female genital tract in older adults derive commonly from somatic epithelial neoplasms: somatically derived yolk sac tumours. Histopathology 69(5):739\u201351","journal-title":"Histopathology"},{"issue":"4","key":"4622_CR15","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/his.13426","volume":"72","author":"FF Nogales","year":"2018","unstructured":"Nogales FF, Prat J, Schuldt M et al (2018) Germ cell tumour growth patterns originating from clear cell carcinomas of the ovary and endometrium: a comparative immunohistochemical study favouring their origin from somatic stem cells. Histopathology 72(4):634\u201347","journal-title":"Histopathology"},{"issue":"12","key":"4622_CR16","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1038\/s41379-019-0341-6","volume":"32","author":"O Fadare","year":"2019","unstructured":"Fadare O, Shaker N, Alghamdi A et al (2019) Endometrial tumors with yolk sac tumor-like morphologic patterns or immunophenotypes: an expanded appraisal. Mod Pathol 32(12):1847\u201360","journal-title":"Mod Pathol"},{"issue":"4","key":"4622_CR17","doi-asserted-by":"publisher","first-page":"100976","DOI":"10.1016\/j.modpat.2026.100976","volume":"39","author":"JJX Li","year":"2026","unstructured":"Li JJX, Chui MH, McCluggage WG et al (2026) Endometrial Carcinomas With a Somatically-derived Yolk Sac Tumor Component Share Molecular Similarities to p53-abnormal Endometrial Carcinomas and Germ Cell Tumors. Mod Pathol 39(4):100976","journal-title":"Mod Pathol"},{"issue":"2","key":"4622_CR18","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/PAS.0000000000001777","volume":"46","author":"DL Kolin","year":"2022","unstructured":"Kolin DL, Konstantinopoulos PA, Campos SM et al (2022) Vulvar yolk sac tumors are somatically derived SMARCB1 (INI-1)-deficient neoplasms. Am J Surg Pathol 46(2):169\u201378","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"4622_CR19","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/his.14709","volume":"81","author":"PM Hammer","year":"2022","unstructured":"Hammer PM, Kolin DL, Charville GW et al (2022) A Subset of SMARCB1 (INI-1)-deficient vulvar neoplasms express germ cell markers. Histopathology 81(3):342\u2013351","journal-title":"Histopathology"},{"issue":"6","key":"4622_CR20","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1097\/PAS.0b013e31827e1e83","volume":"37","author":"S Morita","year":"2013","unstructured":"Morita S, Yoshida A, Goto A et al (2013) High-grade lung adenocarcinoma with fetal lung-like morphology: clinicopathologic, immunohistochemical, and molecular analyses of 17 cases. Am J Surg Pathol 37(6):924\u2013932","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"4622_CR21","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/00000478-199804000-00003","volume":"22","author":"Y Nakatani","year":"1998","unstructured":"Nakatani Y, Kitamura H, Inayama Y et al (1998) Pulmonary adenocarcinomas of the fetal lung type: a clinicopathologic study indicating differences in histology, epidemiology, and natural history of low-grade and high-grade forms. Am J Surg Pathol 22(4):399\u2013411","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"4622_CR22","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1111\/his.12711","volume":"67","author":"M Suzuki","year":"2015","unstructured":"Suzuki M, Yazawa T, Ota S et al (2015) High-grade fetal adenocarcinoma of the lung is a tumour with a fetal phenotype that shows diverse differentiation, including high-grade neuroendocrine carcinoma: a clinicopathological, immunohistochemical and mutational study of 20 cases. Histopathology 67(6):806\u2013816","journal-title":"Histopathology"},{"issue":"9","key":"4622_CR23","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1038\/s41379-018-0057-z","volume":"31","author":"M Suzuki","year":"2018","unstructured":"Suzuki M, Nakatani Y, Ito H et al (2018) Pulmonary adenocarcinoma with high-grade fetal adenocarcinoma component has a poor prognosis, comparable to that of micropapillary adenocarcinoma. Mod Pathol 31(9):1404\u201317","journal-title":"Mod Pathol"},{"key":"4622_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.humpath.2018.04.022","volume":"78","author":"Y Akazawa","year":"2018","unstructured":"Akazawa Y, Saito T, Hayashi T et al (2018) Next-generation sequencing analysis for gastric adenocarcinoma with enteroblastic differentiation: emphasis on the relationship with hepatoid adenocarcinoma. Hum Pathol 78:79\u201388","journal-title":"Hum Pathol"},{"issue":"36","key":"4622_CR25","doi-asserted-by":"publisher","first-page":"8203","DOI":"10.3748\/wjg.v22.i36.8203","volume":"22","author":"K Matsumoto","year":"2016","unstructured":"Matsumoto K, Ueyama H, Matsumoto K et al (2016) Clinicopathological features of alpha-fetoprotein producing early gastric cancer with enteroblastic differentiation. World J Gastroenterol 22(36):8203\u201310","journal-title":"World J Gastroenterol"},{"issue":"7","key":"4622_CR26","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1097\/PAS.0000000000000869","volume":"41","author":"S Yamazawa","year":"2017","unstructured":"Yamazawa S, Ushiku T, Shinozaki-Ushiku A et al (2017) Gastric cancer with primitive enterocyte phenotype. Am J Surg Pathol 41(7):989\u201397","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"4622_CR27","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/PAS.0b013e3181d1dcdd","volume":"34","author":"T Ushiku","year":"2010","unstructured":"Ushiku T, Shinozaki A, Shibahara J et al (2010) SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma. Am J Surg Pathol 34(4):533\u2013540","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"4622_CR28","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1007\/s10120-015-0497-9","volume":"19","author":"T Murakami","year":"2016","unstructured":"Murakami T, Yao T, Mitomi H et al (2016) Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differentiation: a study of 29 cases. Gastric Cancer 19(2):498\u2013507","journal-title":"Gastric Cancer"},{"issue":"3","key":"4622_CR29","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00428-023-03623-5","volume":"483","author":"D Abe","year":"2023","unstructured":"Abe D, Akazawa Y, Yatagai N et al (2023) Clinicopathological characteristics of gastric adenocarcinoma with enteroblastic differentiation and gastric adenocarcinoma with enteroblastic marker expression. Virchows Arch 483(3):405\u201314","journal-title":"Virchows Arch"},{"issue":"1","key":"4622_CR30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/PAS.0b013e31823aafec","volume":"36","author":"T Kinjo","year":"2012","unstructured":"Kinjo T, Taniguchi H, Kushima R et al (2012) Histologic and immunohistochemical analyses of alpha-fetoprotein\u2013producing cancer of the stomach. Am J Surg Pathol 36(1):56\u201365","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"4622_CR31","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s12105-019-01065-7","volume":"14","author":"AA Shah","year":"2020","unstructured":"Shah AA, Jain D, Ababneh E et al (2020) SMARCB1 (INI-1)-deficient adenocarcinoma of the sinonasal tract: a potentially under-recognized form of sinonasal adenocarcinoma with occasional yolk sac tumor-like features. Head Neck Pathol 14(2):465\u201372","journal-title":"Head Neck Pathol"},{"issue":"2","key":"4622_CR32","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1007\/s12105-021-01375-9","volume":"16","author":"B Hazir","year":"2022","unstructured":"Hazir B, \u015e\u00edm\u0219ek B, Erdem\u00edr A et al (2022) Sinonasal SMARCB1 (INI1) deficient carcinoma with yolk sac tumor differentiation: a case report and treatment options. Head Neck Pathol 16(2):596\u2013601","journal-title":"Head Neck Pathol"},{"issue":"4","key":"4622_CR33","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1097\/PAS.0000000000000797","volume":"41","author":"A Agaimy","year":"2017","unstructured":"Agaimy A, Hartmann A, Antonescu CR et al (2017) SMARCB1 (INI-1)-deficient sinonasal carcinoma: a series of 39 cases expanding the morphologic and clinicopathologic spectrum of a recently described entity. Am J Surg Pathol 41(4):458\u201371","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"4622_CR34","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1007\/s12105-022-01423-y","volume":"16","author":"JKM Ng","year":"2022","unstructured":"Ng JKM, Chan JYK, Li JJX et al (2022) SMARCB1 (INI1)-deficient sinonasal carcinoma with yolk sac differentiation showing co-loss of SMARCA4 immunostaining - a case report and literature review. Head Neck Pathol 16(3):934\u201341","journal-title":"Head Neck Pathol"},{"issue":"7","key":"4622_CR35","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1111\/his.15410","volume":"86","author":"K Kosemehmetoglu","year":"2025","unstructured":"Kosemehmetoglu K, Katipoglu K, Brundler MA et al (2025) Paratesticular\/inguinal SMARCB1\/INI1 deficient carcinomas with yolk sac tumour-like differentiation are aggressive somatic malignancies. Histopathology 86(7):1044\u20131052","journal-title":"Histopathology"},{"issue":"3","key":"4622_CR36","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00428-025-04389-8","volume":"488","author":"HV Ravisankar","year":"2026","unstructured":"Ravisankar HV, Einhorn LH, Ulbright TM (2026) SMARCB1\/INI1-deficient carcinoma with yolk sac tumor-like features in the inguinal region of a young man: a case of a deceptive and emerging entity. Virchows Arch 488(3):689\u201393","journal-title":"Virchows Arch"},{"issue":"3","key":"4622_CR37","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1111\/jcmm.16222","volume":"25","author":"W Wruck","year":"2021","unstructured":"Wruck W, Bremmer F, Kotthoff M et al (2021) The pioneer and differentiation factor FOXA2 is a key driver of yolk-sac tumour formation and a new biomarker for paediatric and adult yolk-sac tumours. J Cell Mol Med 25(3):1394\u20131405","journal-title":"J Cell Mol Med"},{"issue":"5","key":"4622_CR38","doi-asserted-by":"publisher","first-page":"728","DOI":"10.3390\/cancers11050728","volume":"11","author":"D Nettersheim","year":"2019","unstructured":"Nettersheim D, Vadder S, Jostes S et al (2019) TCam-2 Cells Deficient for SOX2 and FOXA2 Are Blocked in Differentiation and Maintain a Seminoma-Like Cell Fate In Vivo. Cancers (Basel) 11(5):728","journal-title":"Cancers (Basel)"},{"issue":"11","key":"4622_CR39","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1002\/ijc.35385","volume":"156","author":"M Kotthoff","year":"2025","unstructured":"Kotthoff M, Skowron MA, Bremmer F et al (2025) Induction of SOX17 with stimulation of WNT, TGF-beta, and FGF signaling drives embryonal carcinomas into the yolk-sac tumor lineage resulting in increased cisplatin resistance. Int J Cancer 156(11):2210\u201324","journal-title":"Int J Cancer"},{"issue":"3","key":"4622_CR40","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/his.14933","volume":"83","author":"F Bremmer","year":"2023","unstructured":"Bremmer F, Lubk L, Str\u00f6bel P et al (2023) Updating germ cell tumour pathogenesis - the ability of seminomas for FOXA2-driven extra-embryonic differentiation. Histopathology 83(3):477\u201381","journal-title":"Histopathology"},{"issue":"3","key":"4622_CR41","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/his.14968","volume":"83","author":"C Ricci","year":"2023","unstructured":"Ricci C, Ambrosi F, Franceschini T et al (2023) FoxA2 is a reliable marker for the diagnosis of yolk sac tumour postpubertal-type. Histopathology 83(3):465\u201376","journal-title":"Histopathology"},{"key":"4622_CR42","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.humpath.2018.04.025","volume":"81","author":"AL Rougemont","year":"2018","unstructured":"Rougemont AL, Tille JC (2018) Role of HNF1\u03b2 in the differential diagnosis of yolk sac tumor from other germ cell tumors. Hum Pathol 81:26\u201336","journal-title":"Hum Pathol"},{"issue":"11","key":"4622_CR43","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1038\/s41379-020-0597-x","volume":"33","author":"A Gallo","year":"2020","unstructured":"Gallo A, Fankhauser C, Hermanns T et al (2020) HNF1\u03b2 is a sensitive and specific novel marker for yolk sac tumor: a tissue microarray analysis of 601 testicular germ cell tumors. Mod Pathol 33(11):2354\u201360","journal-title":"Mod Pathol"},{"issue":"5","key":"4622_CR44","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1309\/AJCP7MNCNBCRN8NO","volume":"131","author":"D Nonaka","year":"2009","unstructured":"Nonaka D (2009) Differential expression of SOX2 and SOX17 in testicular germ cell tumors. Am J Clin Pathol 131(5):731\u2013736","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"4622_CR45","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00428-023-03725-0","volume":"484","author":"C Ricci","year":"2024","unstructured":"Ricci C, Ambrosi F, Grillini A et al (2024) Analysis of GATA3 and FOXA2 expression suggests that downregulation of genes involved in the maintenance of a mature yolk sac tumor phenotype may underlie sarcomatoid transformation. Virchows Arch 484(4):709\u201313","journal-title":"Virchows Arch"},{"issue":"4","key":"4622_CR46","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/his.15277","volume":"85","author":"C Ricci","year":"2024","unstructured":"Ricci C, Ambrosi F, Grillini A et al (2024) Immunophenotypical assessment supports that post-chemotherapy glandular tumours of germ cell origin straddle between glandular yolk sac tumour and \u201csomatic-type\u201d adenocarcinoma. Histopathology 85(4):695\u20138","journal-title":"Histopathology"},{"issue":"5","key":"4622_CR47","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s00428-025-04062-0","volume":"487","author":"C Ricci","year":"2025","unstructured":"Ricci C, Melotti S, Di Sciascio L et al (2025) Analysis of HNF1\u03b2 expression suggests that its downregulation is involved in the sarcomatoid transformation of yolk sac tumor. Virchows Arch 487(5):1151\u20134","journal-title":"Virchows Arch"},{"key":"4622_CR48","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-025-04223-1","author":"C Ricci","year":"2025","unstructured":"Ricci C, Di Sciascio L, Ambrosi F et al (2025) The absence of FOXA2 and HNF1\u03b2 expression in vasculogenic mesenchymal lesions of germ cell origin suggests an evolutionary pathway similar to that of sarcomatoid yolk sac tumor. Virchows Arch. https:\/\/doi.org\/10.1007\/s00428-025-04223-1","journal-title":"Virchows Arch"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04622-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-026-04622-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04622-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T05:03:11Z","timestamp":1781758991000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-026-04622-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":48,"alternative-id":["4622"],"URL":"https:\/\/doi.org\/10.1007\/s00428-026-04622-y","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"23 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All clinicopathologic investigations were conducted according to the principles of the Declaration of Helsinki and all information regarding the human material used in this study has been managed using anonymous numerical codes. The study has been approved by the Institutional Review Board (IRB) of CE-AVEC Bologna-Emilia Romagna (68\/2025\/Tess\/AOUBo) and Johns Hopkins Hospital IRB (#00390759). All patients included in the study provided informed consent, after a consultation with the investigators.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The study has been approved by the Institutional Review Board (IRB) of CE-AVEC Bologna-Emilia Romagna (68\/2025\/Tess\/AOUBo) and Johns Hopkins Hospital IRB (#00390759).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study-specific approval by the appropriate ethics committee for research involving humans and\/or animals"}},{"value":"All patients included in the study provided informed consent, after a consultation with the investigators.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent if the research involved human participants"}},{"value":"The authors report no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}